TG Therapeutics | TGTX - أصول متداولة





أصول متداولة تغيير تاريخ
AbbVie USD 33.67B 140M 2026-06
Alaunos Therapeutics USD 970K 1.02M 2026-03
Amgen USD 34.96B 3.49B 2026-06
Ardelyx USD 381.87M 447K 2026-03
Arrowhead Research USD 1.67B 168.34M 2026-06
Bayer EUR 33.64B 1.66B 2026-06
Biogen USD 7.31B 1.88B 2026-06
Corcept Therapeutics USD 439.68M 13.64M 2026-06
Curis USD 16.61M 9.7M 2026-03
Gilead Sciences USD 12.53B 6.11B 2026-06
J&J USD 59.77B 601M 2026-06
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
Novartis USD 27.35B 744M 2026-06
Novavax USD 771.1M 79.72M 2026-06
PTC Therapeutics USD 2.62B 363.36M 2026-06
Puma Biotechnology USD 143.58M 7M 2025-09
Regeneron Pharmaceuticals USD 18.45B 236.8M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
TG Therapeutics USD 1.15B 58.72M 2026-06
Verastem USD 202.9M 20.51M 2026-03
Vertex Pharmaceuticals USD 12.54B 813.4M 2026-06